Purchase Order 75N98026P00566
Award Date 9/1/26
Potential Completion Date 8/31/27
Potential Value $20K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $223,980.33 in Ingenuity Pathway Analysis (IPA) on August 22, 2023, with final completion on August 21, 2025. The order is priced firm fixed and carries no set-aside designation. Work is performed in Germantown, Maryland. The purchase order procures Ingenuity Pathway Analysis software licensing and related bioinformatics tools supporting genomic research and precision medicine analysis.</p>
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging awarded a $175,605.25 firm fixed price purchase order to Qiagen, LLC, a division of Qiagen N.V., to provide Ingenuity Pathway Analysis (IPA) - Match Explorer software. This software will support the biomedical research, public health, and precision medicine programs of HHS agencies like NIH and Centers for Disease Control and Prevention. Qiagen has provided similar genomic analysis...
- Qiagen, LLC has been awarded a firm fixed price purchase order valued at $19,237.01 by the NIH Clinical Center for QIAGEN Ingenuity Pathway Analysis software. The award, issued September 4, 2025, carries an ultimate completion date of October 4, 2025. This contract represents a direct procurement with no set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace. The place of performance is Germantown, Maryland, where Qiagen maintains its U.S. headquarters....
- The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $192,095.00 firm fixed price purchase order to Qiagen, LLC to provide 5 software support license renewals for Ingenuity Pathway Analysis (IPA) software. The contract has a completion date of December 31, 2022 and does not have a set-aside designation. Qiagen, LLC is a division of the international provider Qiagen N.V., which has a history of providing a range...
- This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian agency, to Qiagen, LLC for a concurrent user license of Qiagen's Ingenuity Pathway Analysis (IPA) Match Explorer software. The total ceiling value of the contract is $47,277.00, with a period of performance through May 15, 2023. The contract was not set aside for any small business category. Qiagen, LLC is a division of the parent company Qiagen N.V., an international provider of sample and...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V., to provide IPA (Ingenuity Pathway Analysis) Analysis Match Explorer CL software licenses. The contract has a potential value of $139,495.00 and a performance period ending on August 31, 2023. This award does not utilize any set-aside designations. Qiagen has a history of...
- This purchase order was awarded by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to Qiagen, LLC for $30,512. The contract is for a one-year period from September 2023 through September 2024 and provides a software license for Ingenuity Pathway Analysis Match Explorer. IPA is a web-based software application that allows scientists to analyze and integrate omics data from sources such as RNA-seq and gene expression to understand biological...
- This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Qiagen, LLC, a division of the international provider Qiagen N.V. The $126,230.40 contract is for IPA (Ingenuity Pathway Analysis) analysis services, with a completion date of January 31, 2020. Qiagen has previously provided a range of goods and services, including DNA/RNA extraction kits,...
- This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC for annual software license and support subscription renewals of the QIAGEN Ingenuity Pathway Analysis (IPA) platform. The contract has a ceiling value of $170,495.00 and a performance period ending on December 31, 2021. No set-aside was used for this award. Qiagen, LLC is a...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for software licenses for NIDDK's IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $31,733.00 and a period of performance through September 28, 2025. Qiagen is a global provider of molecular diagnostics, applied testing, and bioinformatics...
The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on September 1, 2026, for Ingenuity Pathway Analysis (IPA) software with a firm fixed price ceiling of $19,748.00. Place of performance is Germantown, Maryland. The order is set to complete on August 31, 2027.
Generated 5/23/26, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 5/21/26 |